Nuve Revenue and Competitors
Estimated Revenue & Valuation
- Nuve's estimated annual revenue is currently $3.9M per year.
- Nuve's estimated revenue per employee is $116,000
Employee Data
- Nuve has 34 Employees.
- Nuve grew their employee count by 0% last year.
Nuve's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Technology Officer | Reveal Email/Phone |
2 | Sales Engineer | Reveal Email/Phone |
Nuve Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $17.5M | 121 | 12% | N/A | N/A |
#2 | $90.4M | 499 | 24% | N/A | N/A |
#3 | $2M | 20 | -23% | N/A | N/A |
#4 | $226.8M | 1094 | 46% | $261M | N/A |
#5 | $406.7M | 2600 | 8% | $26.1M | N/A |
#6 | $14.8M | 102 | -61% | N/A | N/A |
#7 | $8.6M | 66 | -1% | N/A | N/A |
#8 | $13.2M | 91 | -5% | $752.5M | N/A |
#9 | $36.5M | 229 | 6% | N/A | N/A |
#10 | $56.6M | 312 | 23% | N/A | N/A |
What Is Nuve?
Nuve has developed a new technology based on sensors, a cloud-based platform and a mobile application that allows the asset management industry to better protect, control and monitor their property. IoT for the Asset Management indusrty. Austin · Sensors · Location Based Services · Analytics · Internet of Things
keywords:N/AN/A
Total Funding
34
Number of Employees
$3.9M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Nuve News
2022-04-17 - Global Platelet Agitators Market Competitive Analysis ...
Nuve; Boekel Scientific; Newmeditech. Research offering well-studied comprehensions for Platelet Agitators Market. The verified secondary data...
2022-04-17 - Platelet Agitators Market: Increasing prevalence of chronic ...
Major players operating in the global platelet agitators market include Helmer Scientific, SARSTEDT AG & Co, Boekel Scientific, Nuve, Fanem,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.8M | 34 | 0% | N/A |
#2 | $5.6M | 34 | -11% | N/A |
#3 | $7.3M | 34 | 6% | N/A |
#4 | $4.6M | 34 | -8% | N/A |
#5 | $7.3M | 34 | 3% | N/A |